The longest-standing model is that MYC activates a specific set of target genes, estimated to represent over 10% of the mammalian genome under conditions of MYC overexpression12 and that these target genes mediate both its tumorigenic and tumour suppressive functions. The gene discussed is MYC; the disease is neoplasm.